Skip to main content

Update komplementäre Onkologie 2012

Update on complementary oncology 2012

Der Onkologe volume 18, pages 705–710 (2012)Cite this article

Zusammenfassung

Der Versuch einer Prävention von Tumorerkrankungen durch Einnahme von Vitaminen und Spurenelementen ist nicht sinnvoll. Mangelzustände wie Vitamin-D- und Selenmangel sollten allerdings gezielt ausgeglichen werden. Verfahren der komplementären Medizin wie Qigong können vielfältige Beschwerden bei Tumorpatienten verbessern. 2011 erschienen eine Reihe klinischer Studien zu Heilpflanzen. Ingwer und Mariendistel (Silymarin) können unterstützend bei Übelkeit bzw. Leberschäden eingesetzt werden. Sie ersetzen ein leitliniengerechtes Vorgehen nicht. Trotz allen Interesses für chinesische Heilkräutermischungen bleiben die Daten wenig überzeugend – negative Wirkungen sind möglich. Die Wirkung von Granatapfel bei Prostatakarzinomen konnte auch klinisch belegt werden.

Abstract

Vitamins and trace elements as supplements do not prevent cancer. Nevertheless, vitamin D and selenium should be substituted if the serum level is below normal. Complementary treatments like Qigong are able to reduce various complaints in cancer patients. In 2011 several clinical studies with different herbs were published. Ginger and milk thistle can be used as supportive drugs against nausea and hepatotoxicity. However, they are no substitute for supportive treatment as specified in guidelines. Despite great interest in Chinese herbs, clinical evidence is not convincing and negative effects are possible. The efficiency of pomegranate against prostate cancer was demonstrated in a clinical study.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Literatur

  1. Ashamalla H (2011) Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy. Int J Radiat Oncol Phys 79(5):1358–1363

    Article  Google Scholar 

  2. Barton DL, Atherton PJ, Bauer BA et al (2011) The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, NO1C5). J Support Oncol 9(1):24–31

    PubMed  Article  Google Scholar 

  3. Becker-Schiebe M, Mengs U, Schaefer M et al (2011) Topical use of a silimarin-based preparation to prevent radiodermatitis: results of a prospective study in breast cancer patients. Strahlenther Onkol 187(8):485–491

    PubMed  Article  Google Scholar 

  4. Blackmore KM, Lesowsky M, Barnett H et al (2008) Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. Am J Epidemiol 168(8):915–924

    PubMed  Article  Google Scholar 

  5. Bleys J, Navas-Acien A, Guallar E (2011) Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 168(4):404–410

    Article  Google Scholar 

  6. Boehm K, Borrelli F, Ernst E et al (2009) Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 3:CD005004

    PubMed  Google Scholar 

  7. Braga FP (2011) Acupuncture for the prevention of radiation-induced xerostomia in patients with head and neck cancer. Braz Oral Res 25(2):180–185

    PubMed  Article  Google Scholar 

  8. Butler LM, Wu AH (2011) Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res 55(6):931–940

    PubMed  Article  CAS  Google Scholar 

  9. Chan KK, Yao TJ, Jones B et al (2011) The use of chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring. Ann Oncol 22(10):2241–2249

    PubMed  Article  CAS  Google Scholar 

  10. Chung VQ, Tattersall M, Cheung HT (2004) Interactions of a herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother Pharmacol 53(5):384–390

    PubMed  Article  CAS  Google Scholar 

  11. Cohen L, Chen Z, Arun B et al (2010) External qigong therapy for woman with breast cancer prior to surgery. Integr Cancer Ther 9(4):348–353

    PubMed  Article  Google Scholar 

  12. Crew KD, Gammon MD, Steck SE et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2(6):598–604

    Article  Google Scholar 

  13. Deng GE, Chan Y, Yeung KS et al (2011) Acupuncture for chemotherapy induced fatigue: a randomized controlled trial. Abstract 9029. 2011 ASCO Annual Meeting, Chicago. J Clin Oncol [Suppl] 29:2011

  14. Dennert G, Zwahlen M, Brinkman M et al (2011) Selenium for preventing cancer. Cochrane Database Syst Rev 11(5):CD005195

    Google Scholar 

  15. Duffield-Lillico AJ, Dalkin BL, Reid ME et al (2003) Nutritional prevention of cancer study group. BJU Int 91:608–612

    PubMed  Article  CAS  Google Scholar 

  16. Fedirko V, Bostick RM, Flanders WD et al (2009) Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2(3):213–223

    Article  Google Scholar 

  17. Freesman DM, Chang SC, Falk RT et al (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17(4):889–894

    Article  Google Scholar 

  18. Gandini S, Boniol M, Haukka J et al (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424

    PubMed  Article  CAS  Google Scholar 

  19. Gissel T, Rejnmark L, Mosekilde L et al (2008) Intake of vitamin D and risk of breast cancer – a meta-analysis. J Steroid Biochem Mol Biol 111(3–5):195–199

    Google Scholar 

  20. Greven K, Case LD, Nycum LR et al (2011) Does L-arginine/Korean ginseng/Ginkgo biloba/damiana-based supplement improve the sexual function and quality of life of female cancer survivors: a randomized trial. Abstract 9016. 2011 ASCO Annual Meeting, Chicago. J Clin Oncol [Suppl] 29:2011

  21. Hotaling JM, Wright JL, Pocobelli G et al (2011) Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study. J Urol 185(4):1210–1215

    PubMed  Article  CAS  Google Scholar 

  22. Kirste S, Treier M, Wehrle JL et al (2011) Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer 117(16):3788–3795

    PubMed  Article  Google Scholar 

  23. Ladas EJ (2010) A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer 116(2):506–513

    PubMed  Article  CAS  Google Scholar 

  24. Lai TK, Cheung MC, Lo CK et al (2011) Effectiveness of aroma massage on advanced cancer patients with constipation: a pilot study. Complement Ther Clin Pract 17(1):37–43

    PubMed  Article  CAS  Google Scholar 

  25. Ogunleye AA, Xue F, Michels KB (2010) Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 119(2):477–484

    PubMed  Article  Google Scholar 

  26. Oh B, Butow P, Pavlakis N et al (2011) Effect of medical Qigong on cognitive function, quality of life and a biomarker of inflammation in patients with cancer: a randomized controlled trial. Abstract 9035. 2011 ASCO Annual Meeting, Chicago. J Clin Oncol [Suppl] 29:2011

  27. Paley CA, Johnson MI, Tashani OA, Bagnall AM (2011) Acupuncture for cancer pain in adults. Cochrane Database Syst Rev 19(1):CD007753

    Google Scholar 

  28. Paller CJ, Ye X, Wozniak P et al (2011) A phase II study of pomegranate extract for men with rising prostate specific antigen following primary therapy. Abstract 4522. 2011 ASCO Annual Meeting, Chicago. J Clin Oncol [Suppl] 29:2011

  29. Pantuck AJ, Leppert JT, Zomorodian N et al (2006) Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12(13):4018–4026

    PubMed  Article  CAS  Google Scholar 

  30. Perez AT (2010) A phase 1B dose excalation trial of Scutellaria barabata (BZL101) for patients with metastic breast cancer. Breast Cancer Res Treat 120(1):111–118

    PubMed  Article  Google Scholar 

  31. Pillai AK, Sharma KK, Gupta YK, Bakhshi S (2011) Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer 56(2):234–238

    PubMed  Article  Google Scholar 

  32. Saif MW (2010) Phase I study of the botanic formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine 17(3–4):161–169

    Google Scholar 

  33. Stendell-Hollis, Thomson CA, Thompson PA et al (2010) Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet 23(6):590–600

    PubMed  Article  CAS  Google Scholar 

  34. Vitolins M, Griffin L, Tomlinson WV et al (2011) Phase III randomized, double-blind, placebo-controlled trial of soy protein and venlafaxin for treatment of hot flashes in men with prostate cancer. Abstract 9027. 2011 ASCO Annual Meeting, Chicago. J Clin Oncol [Suppl] 29:2011

  35. Worthington HV, Clarkson JE, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 13(4):CD000978

    Google Scholar 

  36. Wu AH, Yu MC, Stanczyk FZ et al (2011) Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutr Cancer 63(4):549–557

    PubMed  Article  CAS  Google Scholar 

  37. Yin L, Grandi N, Raum E et al (2009) Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30(2):113–125

    PubMed  Article  CAS  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Palliativmedizin, Supportive und komplementäre Onkologie, Universitäres Centrum für Tumorerkrankungen (UCT), Johann Wolfgang-Goethe Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    J. Hübner

  2. Klinikum Lemgo, Lemgo, Deutschland

    R. Mücke

  3. Franziskus Hospital Bielefeld, Bielefeld, Deutschland

    O. Micke

  4. Universitätsklinikum Gießen, Gießen, Deutschland

    K. Münstedt

Authors
  1. J. Hübner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Mücke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Micke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Münstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Hübner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hübner, J., Mücke, R., Micke, O. et al. Update komplementäre Onkologie 2012. Onkologe 18, 705–710 (2012). https://doi.org/10.1007/s00761-012-2286-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-012-2286-y

Schlüsselwörter

  • Komplementäre Medizin
  • Alternative Medizin
  • Integrative Onkologie
  • Evidenzbasierte Medizin
  • Supplemente

Keywords

  • Complementary medicine
  • Alternative medicine
  • Integrative oncology
  • Evidence-based medicine
  • Supplements